Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$4.26 - $6.86 $52,824 - $85,064
-12,400 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$3.6 - $8.42 $44,640 - $104,408
12,400 New
12,400 $55,000
Q3 2018

Nov 13, 2018

SELL
$6.33 - $8.08 $179,139 - $228,664
-28,300 Closed
0 $0
Q2 2018

Aug 08, 2018

BUY
$6.93 - $14.63 $196,119 - $414,029
28,300 New
28,300 $198,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $731M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.